Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TGTXTGTX
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in TG THERAPEUTICS INC

Yes. Goldman Sachs holds 2,314,279 shares of TGTX (TG Therapeutics), worth $127.1M, as of its Q2 2026 13F filing. It increased the position by 26,591 shares (+1.2%) from Q1 2026. Goldman Sachs has held TGTX in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$127.1M

Current Shares

2.3M

Total Value Change

+$123.1M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+1.2%
$127.1M0.0%$54.94
30
2026-Q1
Increased
2.3M
+11.5%
$76M0.0%$33.22
33
2025-Q4
Increased
2.1M
+35.0%
$61.1M0.0%$29.81
38
2025-Q3
Decreased
1.5M
-3.2%
$54.9M0.0%$36.13
0
2025-Q2
Decreased
1.6M
-18.2%
$56.5M0.0%$35.99
0
2025-Q1
Increased
1.9M
+21.9%
$75.7M0.0%$39.43
36
2024-Q4
Decreased
1.6M
-38.4%
$47.4M0.0%$30.10
0
2024-Q3
Increased
2.6M
+22.6%
$59.8M0.0%$23.39
36
2024-Q2
Increased
2.1M
+62.0%
$37.1M0.0%$17.79
42
2024-Q1
Decreased
1.3M
-22.0%
$19.6M0.0%$15.21
0
2023-Q4
Decreased
1.6M
-2.4%
$28.2M0.0%$17.08
0
2023-Q3
Increased
1.7M
+19.0%
$14.1M0.0%$8.36
33
2023-Q2
Increased
1.4M
+21.5%
$35.3M0.0%$24.84
35
2023-Q1
Decreased
1.2M
-3.8%
$17.6M0.0%$15.04
0
2022-Q4
Decreased
1.2M
-21.2%
$14.4M0.0%$11.83
0
2022-Q3
Increased
1.5M
+61.5%
$9.1M0.0%$5.92
40
2022-Q2
First report
954,679
-
$4.1M0.0%$4.25
0

Other major holders of TGTX: BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used